Abstract
In order to evaluate the clinical value of a new myocardial perfusion tracer, a series of 30 patients (25 male, 5 female, mean age 56 years) referred for thallium 201 stress/redistribution scintigraphy has been studied using stress/rest (n = 7) or rest/stress (n = 23) protocols with technetium 99m teboroxime (Cardiotec SQUIBB). In all cases coronary artery disease was known or highly probable, with a history of myocardial infarction in 18 cases. Medical treatment was not discontinued at the time of stress testing, and coronary angiography was available in 27 patients. Exercise tests for both tracers were carried out on a bicycle ergometer during the same day, and the levels of exercise achieved for the 201Tl study were very similar to those achieved for 99mTc-teboroxime. Studies performed in three planar projections were evaluated using a model with four territories septal and anterior assumed to correspond to the left anterior descending artery, lateral and lateroposterior (left circonflex), inferior and posterior (right coronary artery) and apex. Classification of results was normal, ischaemic, infarcted and infarcted with ischaemia. On comparison with the 201Tl results, agreement was found in 86% (37/43) of normal regions and in 82% (63/77) of abnormal regions. Relative to documented coronary artery lesions (27 patients), sensitivity and specificity of 201Tl and 99mTc-teboroxime for exact correspondence between arteries and territories were respectively: 201Tl: sensitivity 64%, specificity 60%; 99mTc-teboroxime: sensitivity 62%, specificity 77%. These results, obtained in a given clinical context, indicate the ability of Cardiotec to evaluate myocardial perfusion with a significant saving in time, since the complete study duration (stress and rest) was: 201Tl, 4 h 35 min±21 min; 99mTc-teboroxime, 1 h 52 min ±29 min. Nevertheless, the high liver uptake was responsible for 68% of non-evauble inferior segments and the limited acquisition time makes the applicability of SPET questionable.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Boucher CA, Zir LM, Beller GA, Okada RD, McKusick KA, Strauss HW (1980) Increased lung uptake of thallium-201 during exercise myocardial imaging: clinical, hemodynamic and angiographic implications in patients with coronary artery disease. Am J Cardiol 46:189–196
Deutsch E, Glavan KA, Sodd VJ, Nishiyama H, Ferguson DL, Lukes SJ (1981) Cationic 99mTc complexes as potential myocardial imaging agent. J Nucl Med 22:897–907
Drane WE, Decker M, Strickland P, Tineo A, Zmuda S (1989) Measurement of regional myocardial perfusion using Tc-99m teboroxime (Cardiotec) and dynamic SPELT (abstract). J Nucl Med 30:1744
Gachon P, Moins N, Renoux M, Maublant J (1988) A comparison between thallium-201 and two new technetium-99m labeled myocardial blood flow imaging agents in cultures of cardiac cells (abstract). J Mol Cell Cardiol 20 [Suppl 5]:49
Johnson LL, Seldin DW (1990) Clinical experience with technetium-99m teboroxime, a neutral, lipophilic myocardial perfusion imaging agent. Am J Cardiol 66:63E-67E
Johnson LL, Seldin DW, Muschel MJ, Smith KF, Blood DK, Cannon PJ (1987) Comparison of Planar SQ30217 and Tl-201 myocardial imaging with coronary anatomy (abstract). Circulation 76 [Suppl 4]:217
Karcher G, Bertrand A, Moretti JL, Maublant J, Mathieu E, Itti R, Bourguignon M, Baconnet B (1988) Comparative study by two independent observers of the uptake abnormalities of 201 thallium and Tc-99m-MIBI in 81 patients with coronary artery disease (abstract). J Nucl Med 29:793–794
Liu P, Dawood F, Houle S, Riley R, McLaughlin PR (1988) Myocardial uptake and clearance of new myocardial perfusion tracers SQ32014 and SQ30217 in an isolated heart model: comparison with thallium (abstract). Circulation 78 [Suppl 11]: 126
Maublant J, Gachon P, Moins N (1988) Hexakis (2-methoxy isobutylisonitrile) technetium-99m and thallium-201 chloride: uptake and release in cultured myocardial cells. J Nucl Med 29:48–54
Narra RK, Feld T, Wedeking P, Matyas J, Nunn AD (1986) SQ30217, a technetium 99m labelled myocardial imaging agent which shows no interspecies differences in uptake (abstract). Nuklearmedizin 25:489–491
Okada RD, Glover D, Gaffney T, Williams S (1988) Myocardial kinetics of technetium-99m-hexakis-2-methoxy-2-methylpropyl-isonitrile. Circulation 77:491–498
Seldin DW, Johnson LL, Blood DK, Muschel MJ, Smith KF, Wall RM, Cannon PJ (1989) Myocardial perfusion imaging with technetium-99m SQ 30217: comparison with thallium-201 and coronary anatomy. J Nucl Med 30:312–219
Taillefer R, Dupras G, Sporn V, Rigo P, Léveille J, Boucher P, Perez-Balino N, Camin LL, McKusick KA (1988) Myocardial perfusion imaging with a new radiotracer, technetium-99m-hexamibi (methoxy-isobutyl isonitrile): comparison with thallium-201 imaging. Clin Nucl Med 14:89–96
Taillefer R, Gagnon A, Laflamme L, Grégoire J, Léveille J, Phaneuf DC (1989) Same day injections of Tc-99m methoxy isobutyl isonitrile (hexamibi) for myocardial tomographic imaging: comparison between rest-stress and stress-rest injection sequences. Eur J Nucl Med 15:113–117
Wackers F, Berman D, Maddahi J, Watson D, Beller G, Srauss HW, Boucher C, Picard M, Holman BL, Fridrich R, Inglese E, Delaloye B, Bischof-Delaloye A, Camin L, McKusick K (1989) Technetium-99m hexakis-2-methoxyisobutyl isonitrile: human biodistribution, dosimetry, safety and preliminary comparison to thallium-201 for myocardial perfusion imaging. J Nucl Med 30:301–311
Zielonka JS, Bellinger R, Coleman RE, Drane W, Williams C, Goris M, Johnson L, Seldin D, Leppo J, Reba R, Wassermann A (1989) Multicenter clinical trial of 99m-Tc teboroxime (SQ 30,217; Cardiotec) as a myocardial perfusion agent (abstract). J Nucl Med 30:1745
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bontemps, L., Geronicola-Trapali, X., Sayegh, Y. et al. Technetium-99m teboroxime scintigraphy. Eur J Nucl Med 18, 732–739 (1991). https://doi.org/10.1007/BF00173432
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00173432